Pomalidomide-PEG1-C2-COOH
Pomalidomide-PEG1-C2-COOH is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based cereblon ligand and 1-unit PEG linker used in PROTAC technology[1].
Product Specifications
CAS Number
[2139348-60-8]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
E3 Ligase Ligand-Linker Conjugates
Type
Reference compound
Related Pathways
PROTAC
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/pomalidomide-peg1-c2-cooh.html
Purity
99.88
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
OC(CCOCCNC1=C(C(N(C2C(NC(CC2)=O)=O)C3=O)=O)C3=CC=C1)=O
Molecular Formula
C18H19N3O7
Molecular Weight
389.36
Precautions
H302, H315, H319, H335
References & Citations
[1]Qiu X, et al. Jiang B. Chemoselective Synthesis of Lenalidomide-Based PROTAC Library Using Alkylation Reaction. Org Lett. 2019;21 (10) :3838-3841.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, stored under nitrogen, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Cereblon
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Recombinant Phaseolus vulgaris Bowman-Birk type proteinase inhibitor PVI-3 (2)
Recombinant Phaseolus vulgaris Bowman-Birk type proteinase inhibitor PVI-3 (2)
Recombinant Phaseolus vulgaris Bowman-Birk type proteinase inhibitor PVI-3 (2)
Recombinant Phaseolus vulgaris Bowman-Birk type proteinase inhibitor PVI-3 (2)